Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meloxicam Timing in Prostate Brachytherapy
NCT00152919Phase 3Completed
- Sponsor
- University Health Network
- Start
- Feb 2004
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of meloxicam in prostate cancer (PCa) (2 arms), sponsored by University Health Network. Primary endpoint: Prostate Edema Factor at 1 month. Started Feb 2004; status: completed.
02
Drugs
meloxicam
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00152919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00152919.